Home Cart 0 Sign in  

[ CAS No. 388082-78-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 388082-78-8
Chemical Structure| 388082-78-8
Structure of 388082-78-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 388082-78-8 ]

Related Doc. of [ 388082-78-8 ]

Alternatived Products of [ 388082-78-8 ]

Product Details of [ 388082-78-8 ]

CAS No. :388082-78-8 MDL No. :MFCD18904381
Formula : C43H44ClFN4O11S3 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 943.48 Pubchem ID :-
Synonyms :
GW2016 ditosylate monohydrate;GW572016 ditosylate monohydrate;Lapatinib tosilate hydrate;Lapatinib tosilate;Lapatinib ditoluenesulfonate monohydrate
Chemical Name :N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate) hydrate

Calculated chemistry of [ 388082-78-8 ]

Physicochemical Properties

Num. heavy atoms : 63
Num. arom. heavy atoms : 39
Fraction Csp3 : 0.16
Num. rotatable bonds : 13
Num. H-bond acceptors : 15.0
Num. H-bond donors : 5.0
Molar Refractivity : 239.46
TPSA : 249.46 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.91 cm/s

Lipophilicity

Log Po/w (iLOGP) : 6.03
Log Po/w (XLOGP3) : 4.43
Log Po/w (WLOGP) : 11.92
Log Po/w (MLOGP) : 3.76
Log Po/w (SILICOS-IT) : 5.84
Consensus Log Po/w : 6.4

Druglikeness

Lipinski : 2.0
Ghose : None
Veber : 2.0
Egan : 2.0
Muegge : 3.0
Bioavailability Score : 0.11

Water Solubility

Log S (ESOL) : -8.08
Solubility : 0.00000784 mg/ml ; 0.0000000083 mol/l
Class : Poorly soluble
Log S (Ali) : -9.39
Solubility : 0.000000387 mg/ml ; 0.0000000004 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -12.49
Solubility : 0.0000000003 mg/ml ; 0.0 mol/l
Class : Insoluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 5.79

Safety of [ 388082-78-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 388082-78-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 388082-78-8 ]

[ 388082-78-8 ] Synthesis Path-Downstream   1~65

  • 1
  • [ 231277-92-2 ]
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
88% In methanol; at 45 - 65℃;Reflux; (vi) Preparation of N-{3-chloro-4-[(3-fluorobenzyloxy]phenyl}-6-[5-([2-methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine ditosylate salt (or) Lapatinib ditosylate (anhydrous) l(b) Into a two liter four-necked round bottomed flask, 150OmL of methanol, 25 g of Lapatinib base, obtained from the previous step-(v) were charged. The mass temperature was raised to 60-650C to dissolve the solid completely, and then cooled to 45-5O0C and 18 g of p- toluenesulphonicacid monohydrate dissolved in 50 mL of methanol was added. The reaction mass was maintained at reflux condition for 3 hrs, cooled to 25-35C and filtered. The product was dried under vacuum at 75-80 C to get 35 g(88% of theory) of Lapatinib ditosylate salt as an yellow crystalline solid. Melting point range: 237-239 C Purity: 99.8% by HPLC (vii) Preparation of N{3-chloro-4-[(3-fluorobenzyloxy]phenyl}-6-[5-([2-methane suIphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamineditosylate monohydrate
88% In methanol; at 25 - 65℃; for 3h; (vi) Preparation of N-{3-chloro-4-[(3-fluorobenzyloxy]phenyl}-6-[5-([2-methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine ditosylate salt (or) Lapatinib ditosylate (anhydrous) 1(b)Into a two liter four-necked round bottomed flask, 1500 mL of methanol, 25 g of Lapatinib base, obtained from the previous step-(v) were charged. The mass temperature was raised to 60-65 C. to dissolve the solid completely, and then cooled to 45-50 C. and 18 g of p-toluenesulphonicacid monohydrate dissolved in 50 mL of methanol was added. The reaction mass was maintained at reflux condition for 3 hrs, cooled to 25-35 C. and filtered. The product was dried under vacuum at 75-80 C. to get 35 g (88% of theory) of Lapatinib ditosylate salt as an yellow crystalline solid.Melting point range: 237-239 C.Purity: 99.8% by HPLC
80% In tetrahydrofuran; at 20 - 60℃;Product distribution / selectivity; Compound F (1 wt) and 2-(methylsulfonyl)ethylamine hydrochloride (0.4 wt, 162 equiv.) were suspended in THF (10 vols). Sequentially, acetic acid (0.354 vol., 4 equiv.) and di-isopropylethylamine (DIPEA, 1.08 vol., 4.07 equiv.) were added. The resulting solution was stirred at 30-35C for ca 1 hour then cooled to ca 22C. Sodium tri-acetoxyborohydride (0.66 wt, 2.01 equiv.) was then added as a continual charge over approximately 15 minutes (some effervescence is seen at this point). The resulting mixture was stirred at ca 22C for ca 2 hours then sampled for HPLC analysis. The reaction was quenched by addition of aqueous sodium hydroxide (25% w/w, 3 vols.) followed by water (2 vols.) and stirred for ca 30 minutes (some effervescence was seen at the start of the caustic addition).The aqueous phase was then separated, extracted with THF (2 vols) and the combined THF extracts were then washed twice with 25% w/v aqueous ammonium chloride solution (2 x 5 vols)2. A solution of p-toluenesulfonic acid monohydrate (p- TSA, 0.74 wt, 2.5 equiv.) in water (1 vol)1 was prepared, warmed to ca 6O0C, and GW572016F (Compound G) (0.002 wt) seeds were added.The THF solution of the free base of GW572016 was added to the p-TSA solution over at least 30 minutes, while maintaining the batch temperature at 60+/-3C. The resulting suspension was stirred at ca 600C for 1-2 hours, cooled to 20-250C over an hour and aged at this temperature for ca 1hr. The solid was collected by filtration, washed with 95:5 THF:Water (3 x 2 vols) and dried in vacuo at ca 35C to give GW572016F - compound G as a bright yellow crystalline solid. Expected yield 80% theory, 117% w/w.1 Minimum reaction volume ca 1 vol.2 Maximum reaction volume ca 17 vol.No. Corrected for assay.
73.2% In tetrahydrofuran; at 65℃; for 6h; To 2L three-mouth bottle nepalese pulls the handkerchief for (II) compound added to the base solution, heating to 65 C, dropping the toluene sulfonic acid monohydrate (73g, 0.384mol) tetrahydrofuran (730 ml) solution, temperature control reaction 6h, cooling and filtering, 45 C drying results in the type crude product of compound (I) (145.2g).The crude product (145g,), tetrahydrofuran/water (7/3, volume ratio ) mixed solvent (1450 ml) add 2L in three-mouth bottle, the temperature rising to 65 C full dissolved, add 20g activated carbon, stirring 30 min, the heat filters, filtrate cooling crystallization, filtration, 45 C lapatinib toluene-P-sulfonic acid drying, the compound of formula (I) 130g, HPLC purity 99.50%, yield 73.2%.
72% In methanol; water; N,N-dimethyl-formamide; at 20 - 67℃; for 1h;Heating / reflux;Product distribution / selectivity; Preparation of Anhydrate Form 2 by crystallization with seeding: Lapatinib (1.0 g) was heated to reflux in a mixture of methanol (32 ml) and dimethylformamide (8 ml) so that the solid dissolved. P-toluenesulfonic acid monohydrate (0.67 g) was added at this temperature (67C) and the heat source was removed. When the temperature had dropped to 62C, 2% w/w anhydrate Form 2 seed (0.032 g), prepared by methods similar to those of Example 1 , was added to the solution. Crystals began to precipitate rapidly and the suspension was allowed to cool to ambient temperature and stirred for a further 1 hour. The product was filtered and dried in the vacuum oven at 400C. Yield 1.15 g (72%) An infrared spectrum was run on the resulting solid and was found to be consistent with Anhydrate Form 2.
60% In 1,4-dioxane; water; at 20℃; for 1h; Lapatinib free base (1.0 g) was heated in a mixture of 1 ,4-dioxane (36 ml) and water (4 ml) until the solid dissolved. P-toluenesulfonic acid monohydrate (0.66 g) was added at this temperature and the solution was allowed to cool. Crystals were precipitated and the suspension was stirred at ambient temperature for a further 1 hour. The product was filtered and dried in the vacuum oven at 60C for 24 hours. Yield 0.96 g (60%). An X-ray powder diffraction pattern and an infrared spectrum were obtained and are depicted in Figure 2(a) and Figure 2(b) respectively.
33% In tetrahydrofuran; at 50℃; for 1h; 50 mg of the starting material (synthesized in Example 5) was added5- (4- (3-chloro-4- (3-fluorobenzyloxy) phenylamino) -quinazolin-6-yl) furan-2-carbaldehyde hydrochlorideWas added to 1 ml of dichloromethane and N, N-diisopropylethylamine (25 mg, 2 eq) was added,Stirring to dissolve,And 2- (methylsulfonyl) ethylamine (24 mg, 2 eq) was added,The mixture was stirred at room temperature (18 C) until the starting reaction was completed,Evaporated to dryness under reduced pressure DCM (dichloromethane)And dissolved in 1 ml of tetrahydrofuran, and NaHB (OAc) 3 (124 mg, 6 eq) was added,Stirring at room temperature until the reaction of the raw material is completed,An aqueous Na2CO3 solution (1 ml, 5%) was added and extracted with ethyl acetate(1 ml x 2), the organic layers were combined, washed with saturated brine (1 ml x 1), the organic layer was dried,Evaporated to dryness to give 50 mg of a brown oil.50 mg of a brown oil was dissolved in 1 ml of THF,A solution of t-toluenesulfonic acid (33 mg, 2 eq) in THF (0.5 ml) was added dropwise to a temperature of 50 C,After stirring for 1 hour, the mixture was cooled to room temperature (15 C), filtered and the filter cake was washed with THF (1 ml x 2) and dried to give 49 mg of a yellow solid which was added to 1 ml of THF / H2O (4/1)Heated to 60 C to dissolve and clarify, and slowly lower the temperature to room temperature (15 C) after stirring for 1 hour,The temperature was further reduced to 0 C, stirred for 1 hour and then filtered. The filter cake was washed with THF (1 ml * 2)After drying in vacuo, 30 mg of a yellow solid was obtained. Yield: 33%, purity 99%
at 25℃; for 16h;Neat (no solvent);Product distribution / selectivity; Example 1To 0.1 gr solid lapatinib base Form X sample, 0.065 gr of p-toluenesulfonic acid was added to obtain a yellow solid. The resulting dry solid was stirred over 16 h at 25 C. The cake thus obtained, identified as Form I of lapatinib ditosylate.
In tetrahydrofuran; at 55℃; for 2.5h; 5- (4- [3-chloro-4- (3-fluorobenzyloxy)-anilino]-6-quinazolinyl)-furan-2- carbaldehyde 4-methylbenzenesulfonate (1 wt) and 2- (methylsulfonyl) ethylamine hydrochloride (0.4 wt, 1.6equiv) were suspended in THF (10vol). Sequentially, acetic acid (0. 35vol, 4equiv) and di-isopropylethylamine (1. 08vol, 4equiv) were added. The resulting solution was stirred at 30-35C for ca 1 hour then cooled to ca 23C. Sodium triacetoxyborohydride (0.66wt, 2equiv) was then added as a continual charge over approximately 15 minutes (some effervescence is seen at this point). The resulting mixture was stirred at ca 22C for ca 2 hours then sampled for HPLC analysis. The reaction was quenched by addition of 5M aqueous sodium hydroxide (5vol) and stirred for ca 30 minutes (some effervescence is seen at the start of the caustic addition). The aqueous phase was then separated, extracted with THF (2vol) and the combined THF extracts were then washed with 10% w/v aqueous sodium chloride solution (4vol). A solution of p-toluenesulfonic acid monohydrate (pTSA, 1.77wt, 6equiv) in THF (7 vol) 1 was prepared and warmed to ca 55C. The THF solution of N- {3-Chloro-4- [ (3-fluorobenzyl) oxy] phenyl}-6- [5- ( { [2- (methanesul phonyl) ethyl] amino} methyl)- 2-furyl]-4-quinazolinamine was added to the pTSA solution over at least 30minutes, maintaining the batch temperature at ca 553C 2. The resulting suspension was stirred at ca 55C for 2 hours, cooled to 20-25C over ca 60 minutes and aged at this temperature for ca 30 minutes. The solid was collected by filtration, washed with THF (2 x 2vol) and dried in vacuo at ca 40C to give the desired compound as a pale yellow crystalline solid.
In N,N-dimethyl-formamide; Example 24: preparation of lapatinib ditosylate.[000125] P-toluenesulfonic acid was added to a solution of lapatinib-base in 5 V dimethylformamide, 8.03 gr (2eq) to obtain a brownish solution. The solution was seeded with lapatinib ditosylate at 4O0C, then it was stirred for lhour, to obtain a yellow suspension. Then, it was cooled to O0C for 6 hours, and stirred for 10 hours. The resulting suspension was deep-cooled to -1O0C for 2 hours, and stirred for 2 hours. The precipitate was filtered to obtain lapatinib ditosylate.
In methanol; acetonitrile;Heating / reflux; Lapatinib ditosylate anhydrate (form 1) and monohydrate were prepared according to methods similar to those disclosed in International Patent Application No. PCT/US01 /20706, filed June 28, 2001 , and published as WO 02/02552 on January 10, 2002,Single crystal of crystalline anhydrate form 1 was obtained by evaporating a drop of a solution of crystalline anhydrate form 1 in DMSO. Crystal structure data for lapatinib ditosylate anhydrate form 1 was collected on a Bruker Smart CCD 6000 X-ray diffractometerEmpirical formula C29H28CIFN4O4S 2C7H7O3SFormula weight 925.44 Temperature 120(2) KWavelength 0.71073 ACrystal system TriclinicSpace group P -1Unit cell dimensions a = 9.1440(3) A alpha= 95.9840(10). b = 13.2319(4) A beta= 90.8060(10). c = 18.1463(6) A gamma = 100.4050(10).Volume 2146.48(12) A3Z 2Density (calculated) 1.432 Mg/m3; Seed preparation: Lapatinib ditosylate anhydrate Form 1 (~ 0.15 g) (Prepared by the addition p-toluenesulfonic acid to a solution of the free base in a mixture of methanokacetonitrile, 7:3 (40 volumes) at reflux then cooled) However, any preparation of anhydrate form 1 is suitable, i.e. not restricted to using a mixture of methanokacetonitrile, was charged to a 10 ml grinding jar and methanol (0.03 ml) was added. The contents of the jar were ground for 30 minutes by an 8mm grinding ball at 30 Hz using a Retsch mixer mill. An infrared spectrum was run on the resulting solid and was found to be consistent with Anhydrate Form 2.
In water; N,N-dimethyl-formamide; at 20℃; for 0.533333h;Product distribution / selectivity; A mixture of Lapatinib free base (1.0 g) and p-toluenesulfonic acid monohydrate (0.66 g) was stirred in dimethylformamide (2 ml) at ambient temperature. Initially the solids dissolved but in less than 2 minutes crystals were rapidly precipitated and amassed so that more dimethylformamide (2 ml) had to be added to mobilise. The suspension was stirred at <n="28"/>ambient temperature for 30 minutes then the product was filtered, washed with dimethylformamide (2 x 2 ml) and dried in the vacuum oven at 600C for 2 hours. An X-ray powder diffraction pattern and an infrared spectrum were obtained and are depicted in Figure 3(a) and Figure 3(b) respectively.
In water; acetic acid; at 20℃; for 2h;Product distribution / selectivity; Alternative preparation of Lapatinib ditosylate Anhydrate Form 6: Lapatinib free base (1.0 g) was stirred in acetic acid (10 ml) at ambient temperature so that the solid dissolved. P-toluenesulfonic acid monohydrate (0.67 g) was added and crystals were precipitated in less than 2 minutes. The resulting suspension was stirred for 2 hours at ambient temperature then the solid was filtered, washed with acetic acid and dried under vacuum for 3 <n="29"/>hours. An X-ray powder diffraction pattern, an infrared spectrum, and NMR were obtained and the X-ray powder diffraction pattern and an infrared spectrum were different. The NMR was consistent but contained 11.4%w/w acetic acid. The sample was dried further in the vacuum oven at 600C for 24 hours. An X-ray powder diffraction, an infrared spectrum, and an NMR were obtained and were consistent with Form 6.
In methanol; for 3h;Reflux; (vii) Preparation of N-{3-chloro-4-[(3-fluorobenzyloxy]phenyl}-6-[5-([2-methanesulphonyI)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine ditosylate salt (or) Lapatinib ditosylate (anhydrous) 1(b)Into a two liter four-necked round bottomed flask, 1500mL of methanol, 25 g of Lapatinib base, obtained from the previous step-(vi) were charged. The mass temperature was raised to 60-65C to dissolve the solid completely, and then cooled to 45-50C and 18 g of p-toluenesulphonicacid monohydrate dissolved in 50 mL of methanol was added. The reaction mass was maintained at reflux condition for 3 hrs, cooled to 25-35C and filtered. The product was dried under vacuum at 75-80 C to get 35 g(88% of theory) of Lapatinib ditosylate salt as an yellow crystalline solid. Melting range: 237-239 CPurity: 99.8% by HPLC
at 20℃; for 5h;Reflux; Example 4: Synthesis of N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2- (methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine ditosylate (lapatinib ditosylate)ITo a suspension of 2-(methylsulfonyl)ethanamine hydrochloride (SM4.HC1; 12.2 g, 76.7 mmol) in THF (600 mL) was added acetic acid (14.1 g, 235 mmol) followed by DIPEA (30.3 g, 235 mmol) were added. After stirred at ambient temperature for 0.5 h, ¾0 (4.2 g, 233 mmol) and IM3.HC1 (30.0 g, HPLC assay >99%, 58.7 mmol) were added. After being stirred at ambient temperature (20C) for 4 h, sodium triacetoxyborohydride (37.4 g, 176 mmol) was added and the mixture was stirred at ambient temperature (20C+/-5C; external temperature) until HPLC showed the completion of the reaction. A 10% aqueous solution of sodium hydroxide (90 mL) was added and the mixture was stirred for 30 min. The organic phase was washed with 25% aqueous NH4C1 (60 mL), filtered, treated with -TsOH (40.4 g, 135 mmol) and heated to reflux for 2 h. The mixture was cooled to ambient temperature and stirred for 3 h at ambient temperature. The mixture was filtered, and the filter cake was washed twice with THF (120 mL each) and was then dried under vacuum at 70+/-5C for 6 h to give 43 g (46.5 mmol) lapatinib ditosylate with 99.4% HPLC purity.Lapatinib ditosylate [H NMR (300 MHz, d6-DMSO): delta 11.41(s, 2H), 9.33 (s, 3H), 9.04 (d, / = 1.3 Hz, 2H), 8.93 (s, 2H), 8.41 (dd, J =8.8, 1.6 Hz, 2H), 7.91 (d, J = 2.6 Hz, 2H), 7.54-7.41 (m, 9H), 7.37 - 7.27 (m, 6H), 7.25 (d, / = 3.4 Hz, 2H), 7.22 - 7.13 (m, 2H), 7.08 (dd, / = 8.4, 0.6 Hz, 8H), 6.87 ( d, / = 3.5 Hz, 2H), 5.29 (s, 4H), 4.46 (s, 4H), 3.65 - 3.51 (m, 4H), 3.51 - 3.38 (m, 4H), 2.26 (s, 12H).A solution of lapatinib ditosylate was converted to its free base form, lapatinib, by washing a solution with aqueous NaOH followed by concentration. Lapatinib: XH NMR (300 MHz, d6-DMSO): delta 2.98 (t, / = 6.75 Hz, 1H), 3.04 (s, 1H), 3.29 (t, J = 6.6 Hz, 1H), 3.83 (s, 1H), 5.28 (s, 1H), 6.50 (d, / = 3.0 Hz, 1H), 7.08 (d, / = 3.3 Hz, 1H), 7.20 (m, 1H), 7.33 (m, 4H), 7.48 (m, 1H), 7.76 (m, 1H), 7.80 (d, 7 = 9 Hz, 1H), 8.04 (d, 7 = 2.75 Hz, 1H), 8.17 (dd, / = 8.7 Hz, / = 1.8 Hz, 1H), 8.56 (s, 1H), 8.75 (d, J = 1.8 Hz, 1H).
In isopropyl alcohol; at 25 - 82℃;Product distribution / selectivity; A mixture of Lapatinib base (2 g) and isopropyl alcohol (18 mL) were heated to 70-75C. Seeds of Lapatinib ditosylate form APO-I (0.1 g) were added, followed by p-toluenesulfonic acid monohydrate (1.37 g, 2.1 eq.), and rinsed with isopropanol (2 mL). The suspension was heated to 80-82C for IS about 4 h. The mixture was cooled down slowly to 25-30C, filtered, washed with isopropanol (5 mL) and suction dried to provide Lapatinib ditosylate isopropanol solvate (APO-II). The APO-II product obtained was subjected to PXRD analysis. The results of the PXRD analysis were substantially similar to those shown in Figure 3.Lapatinib ditosylate isopropanol solvate from above was dried in vacuo at 45-50C for about 1 day to provide 3.0 g of Lapatinib ditosylate form APO-I. The APO-I product formed was subjected to PXRD analysis. The results of the PXRD analysis were substantially similar to those shown in Figure 1.
In Isopropyl acetate; at 65 - 70℃; for 1h;Product distribution / selectivity; Example 9:Preparation of anhydrous form of lapatinib ditosylateLapatinib (63 gm) was dissolved in isopropyl acetate (1575 ml) at 25 to 30C.The contents were heated to reflux and then added p-toluenesulfonic acid (44 gm). The reaction mass was stirred for 1 hour at 65 to 70C and then cooled to 25 to 30C. The reaction mass was stirred for 1 hour at 25 to 30C and filtered. The solid obtained was dried under vacuum at 50 to 55C for 7 hours to obtain 75 gm of anhydrous form of lapatinib ditosylate.
37.0 g In N,N-dimethyl-formamide; at 35 - 40℃; for 1h;Inert atmosphere; Example 7 Preparation of Lapatinib Ditosylate According to the Preferred Aspects of the Invention Synthetic Scheme Into a glass flask fitted with a condenser, thermometer, mechanical stirrer, addition funnel and nitrogen inlet are loaded (under an atmosphere of nitrogen) 25 g (1 equiv.) of 2,2,2-trifluoro-N-[5-(4-hydroxyquinazolin-6-yl) furan-2-yl]methyl}-N-[2-(methylsulphonyl)ethyl]acetamide of formula (IV, R=CF3(CO) and 250 mL (10 V) of dioxane. 17.3 g equal to 10.5 mL (2 equiv.) of phosphorus oxychloride (MW=153.33; d=1.645 g/mL) are added with caution at a temperature of 20-25 C. 11.4 g equal to 15.7 mL (2 equiv.) of triethylamine (MW=101.19; d=0.726 g/mL) are added with caution at a temperature of 20-25 C. On completion of addition, the mixture is allowed to return to room temperature and then stirred at 95-100 C. (reflux) for 1 h. The conversion is monitored by HPLC. If the reaction has gone to completion, the reaction mixture is evaporated to residue in a rotavapor at a max. temperature of 40 C. The residue is then taken up with 250 mL (10 V) of dioxane and evaporated to residue. The residue contains N-[5-(4-chloroquinazolin-6-yl)furan-2-yl]methyl}-2,2,2-trifluoro-N-[2-(methylsulphonyl)ethyl]acetamide of formula (V; R=CF3(CO), X=Cl). This is then taken up with 200 mL (8 V) of Dioxane. The preparation is heated to 55-60 C. and over a time of approx. 15 min., a solution of 14.2 g (1.0 equiv.) of 3-chloro-4-[(3-fluorobenzyl)oxy]aniline of formula (VI) (MW=251.68) dissolved in 50 mL (2 V) of dioxane added. The mixture is heated to 55-60 C. and stirred for 1 hour. The conversion is monitored by HPLC. If the reaction has gone to completion, a solution is prepared with 47 g (6 equiv.) of potassium carbonate (MW=138.21) in 250 mL (10 V) of purified water. The potassium carbonate solution is added to the reaction mixture at T=55-60 C. The reaction mixture is heated to 80-85 C. and stirred for 2 h. The conversion is monitored by HPLC. If the reaction has gone to completion, it is cooled to 20-25 C. The pH is adjusted to >12 using the required quantity of 30% sodium hydroxide. The phases are separated. The aqueous phase is extracted with 250 mL (10 V) of Isopropyl acetate. The organic phase is separated and combined with the previously separated organic phase. The combined organic phases are washed with 125 mL (5 V) of a 10% sodium chloride solution. The combined organic phases are evaporated to residue in a rotavapor at a max. temperature of 40 C. 125 mL (5 V) of DMF (dimethylformamide) are added to the residue. The preparation is heated to 35-40 C. and 22.5 g (2.1 equiv.) of p-toluenesulphonic acid monohydrate (MW=190.22) added. The preparation is stirred for 1 h at 35-40 C. then cooled to 20-25 C. It is preferable that crystallization be initiated with 250 mg (1% wt.) of Lapatinib ditosylate. On achieving precipitation, the preparation is cooled to 0-5 C. and stirred for at least 1 h. The preparation is cooled to -15/-10 C. and stirred for 2 h. The panel is filtered and washed with 12.5 mL (0.5 V) of DMF chilled to -10/-5 C. The wet product is removed and taken up with 125 mL (5 V) of DMF. The preparation is heated to 40-45 C. and stirred at said T for 1 h. The preparation is cooled spontaneously to 20-25 C. and stirred for 1 h. The preparation is cooled to 20-25 C. and stirred for 1 h. The preparation is cooled to 0-5 C. and stirred for 1 hour. The preparation is cooled to -15/-10 C. and stirred for 2 h. The preparation is filtered washing the solid with 2*12.5 mL (2*0.5 V) of DMF pre-chilled to -15/-10 C. The solid is dried at 70 C. under vacuum for at least 10 hours. 37.0 g of lapatinib ditosylate are obtained, corresponding to an overall molar yield of 71%. HPLC purity A/A % 99.9%.
In tetrahydrofuran; water; at 20 - 60℃; for 3.5h; Compound F (1 wt) and 2- (methylsulfonyl)ethylamine (0.4 wt, 1.62 equiv. ) were suspended in THF (10 vols). Sequentially, acetic acid (0.354 vol., 4 equiv. ) and di-isopropylethylamine (DIPEA, 1.08 vol. , 4.01 equiv. ) were added. The resulting solution was stirred at 30-35C for ca 1 hour then cooled to ca 22C. Sodium tri-acetoxyborohydride (0.66 wt, 2.01 equiv. ) was then added as a continual charge over approximately 15 minutes (some effervescence is seen at this point). The resulting mixture was stirred at ca 22C for ca 2 hours then sampled for HPLC analysis. The reaction was quenched by addition of aqueous sodium hydroxide (25% w/w, 3 vols. ) followed by water (2 vols. ) and stirred for ca 30 minutes (some effervescence was seen at the start of the caustic addition). The aqueous phase was then separated, extracted with THF (2 vols) and the combined THF extracts were then washed twice with 25% w/v aqueous ammonium chloride solution (2 x 5 VOIS)2 . A solution of p-toluenesulfonic acid monohydrate (p- TSA, 0.74 wt, 2.5 equiv. ) in water (1 vol) ¹ was prepared, warmed to ca 60C, and GW572016F (Compound G) (0.002 wt) seeds were added. The THF solution of the free base of GW572016 was added to the p-TSA solution over at least 30 minutes, while maintaining the batch temperature at 60No.3C. The resulting suspension was stirred at ca 60C for 1-2 hours, cooled to 20-25C over an hour and aged at this temperature for ca 1hr. The solid was collected by filtration, washed with 95: 5 THF: Water (3 x 2 vols) and dried in vacuo at ca 35C to give GW572016F - compound G as a bright yellow crystalline solid.
In tetrahydrofuran; water; at 60℃; for 2.5h; The aqueous phase was then separated, extracted with THF (2 vols) and the combined THF extracts were then washed twice with 25% w/v aqueous ammonium chloride solution (2 x 5 vols) (at). A solution of p-toluenesulfonic acid monohydrate (p- TSA, 0.74 wt, 2.5 equiv. ) in water (1 vol) ¹ was prepared, warmed to ca 60C, and GW572016F (Compound G) (0.002 wt) seeds were added. The THF solution of the free base of GW572016 was added to the p-TSA solution over at least 30 minutes, while maintaining the batch temperature at 60No.3C. The resulting suspension was stirred at ca 60C for 1-2 hours, cooled to 20-25C over an hour and aged at this temperature for ca 1hr. The solid was collected by filtration, washed with 95: 5 THF: Water (3 x 2 vols) and dried in vacuo at ca 35C to give GW572016F - compound G as a bright yellow crystalline solid. Expected yield 80% theory, 117% w/w.
In tetrahydrofuran; water; at 20 - 63℃; for 3 - 4h; A solution of p-toluenesulfonic acid monohydrate (pTSA, 1.77wt, thetaequiv) in THF (7 vol)1 was prepared and warmed to ca 55C. The THF solution of N- {3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-([2-(methanesulphonyl) ethyl] amino}methyl)- 2-furyl]-4-quinazolinamine was added to the pTSA solution over at least 30minut.es, maintaining the batch temperature at ca 55+/-3C 2. The resulting suspension was stirred at ca 55C for 2 hours, cooled to 20-25C over ca 60 minutes and aged at this temperature for ca 30 minutes. The solid was collected by <n="45"/>filtration, washed with THF (2 x 2vol) and dried in vacuo at ca 400C to give the desired compound as a pale yellow crystalline solid.; A solution of p-toluenesulfonic acid monohydrate (p-TSA, 0.74 wt, 2.5 equiv.) in water (1 vol) is prepared, warmed to ca. 600C, and lambda/-(3-chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-([2- (methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine 4- methylbenzenesulfonate hydrate seeds are added. The THF solution of the free base is added to the p-TSA solution over at least 1 hr, maintaining the batch temperature at 60+/-3C. The resulting suspension is stirred at ca. 600C for 1-2 hours, cooled to 20-250C over an hour and aged at this temperature for ca. 1 hr. The solid is collected by filtration, washed with 95:5 THF: Water (3 x 2 vols) and dried in vacuum at ca. 35C to give lambda/-(3-chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-([2- (methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine 4- methylbenzenesulfonate hydrate as a bright yellow crystalline solid.
In tetrahydrofuran; at 20 - 55℃; for 4h; The aqueous phase was then separated, extracted with THF (2vol) and the combined THF extracts were then washed with 10%w/v aqueous sodium chloride solution (4vol). A solution of p-toluenesulfonic acid monohydrate (pTSA, 1.77wt, 6equiv) in THF (7 vol) (at) was prepared and warmed to ca 55C. The THF solution of N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl)-6-[5-([2- (methanesulphonyl) ethyl] amino}methyl)- 2-furyl] -4-quinazolinamine was added to the pTSA solution over at least 30minutes, maintaining the batch temperature at ca 55No.3C 2. The resulting suspension was stirred at ca 55C for 2 hours, cooled to 20-25C over ca 60 minutes and aged at this temperature for ca 30 minutes. The solid was collected by filtration, washed with THF (2 x 2vol) and dried in vacuo at ca 40C to give the desired compound as a pale yellow crystalline solid.

Reference: [1]Patent: WO2010/61400,2010,A1 .Location in patent: Page/Page column 17
[2]Patent: US2011/263852,2011,A1 .Location in patent: Page/Page column 12
[3]Patent: WO2006/26313,2006,A2 .Location in patent: Page/Page column 24-25
[4]Patent: CN105503839,2016,A .Location in patent: Paragraph 0046; 0049; 0050
[5]Patent: WO2009/79541,2009,A1 .Location in patent: Page/Page column 24
[6]Patent: WO2009/79541,2009,A1 .Location in patent: Page/Page column 25
[7]Patent: CN106432205,2017,A .Location in patent: Paragraph 0052; 0053; 0054
[8]Patent: US2009/281315,2009,A1 .Location in patent: Page/Page column 9
[9]Patent: WO2005/46678,2005,A1 .Location in patent: Page/Page column 69-70
[10]Patent: WO2010/17387,2010,A2 .Location in patent: Page/Page column 30
[11]Patent: WO2009/79541,2009,A1 .Location in patent: Page/Page column 23; 24
[12]Patent: WO2009/79541,2009,A1 .Location in patent: Page/Page column 25-26
[13]Patent: WO2009/79541,2009,A1 .Location in patent: Page/Page column 26-27
[14]Patent: WO2011/39759,2011,A1 .Location in patent: Page/Page column 16; 17
[15]Patent: WO2011/116634,2011,A1 .Location in patent: Page/Page column 16-17
[16]Patent: WO2011/130831,2011,A1 .Location in patent: Page/Page column 15; 16
[17]Patent: WO2012/17448,2012,A2 .Location in patent: Page/Page column 10-11
[18]Patent: US2015/65710,2015,A1 .Location in patent: Page/Page column 0123-0125
[19]Patent: WO2005/120512,2005,A2 .Location in patent: Page/Page column 25
[20]Patent: WO2005/120504,2005,A2 .Location in patent: Page/Page column 32
[21]Patent: WO2007/121279,2007,A2 .Location in patent: Page/Page column 42; 45
[22]Patent: WO2005/105094,2005,A2 .Location in patent: Page/Page column 46-47
  • 2
  • [ 388082-78-8 ]
  • N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-([2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine bis(4-methylbenzenesulphonate) monohydrate [ No CAS ]
YieldReaction ConditionsOperation in experiment
100% With water; Under an atmosphere of nitrogen, 50.0g of <strong>[388082-78-8]Lapatinib ditosylate</strong>and 500 mL of waterare loaded into a four-necked glass round-bottomed flask fitted with amechanical stirrer, condenser and thermometer. This mixture is stirred for 36hours at room temperature.The product is filtered, drainingthoroughly, and then washed with the same mother liquor. The productis dried at room temperature insidea round-bottomed flask fitted with a stirrer under a stream of nitrogen.Theproduct is then dried for 24 hours at 55 C.until obtaining a K.F. value of around 1.92%.51 g of productare obtained, giving a quantitative molar yield.
With water; In tetrahydrofuran; at 55 - 60℃; for 0.5h; Preparation of monohydrate ditosylate salt of N-{3-Chloro-4-[(3- fluorobenzyl)oxy]phenyl}-6-[5-([2-(methane sulphonyl) ethyl]amino}methyl)-2-furyl]- 4-quinazolinamine (monohydrate ditosylate salt of compound of formula (III)) A suspension of the anhydrous ditosylate salt of N- {3-Chloro-4- [ (3- fluorobenzyl) oxy] phenyl}-6- [5- ( { [2- (methane sulphonyl) ethyl] amino} methyl)-2-furyl]-4- quinazolinamine (1 wt), in tetrahydrofuran (THF, 14 vol) and water (6 vol) was heated to ca 55-60C for 30 minutes to give a solution which was clarified by filtration and the lines washed into the crystallisation vessel with THF/Water (7: 3,2 vol). The resultant solution was heated to reflux and tetrahydrofuran (9 vol, 95% w/w azeotrope with water) was distilled off at atmospheric pressure. The solution was seeded with N- {3-Chloro-4- [ (3-fluorobenzyl) oxy] phenyl}-6- [5-([2-(methane sulphonyl)ethyl] amino} methyl)-2-furyl]-4-quinazolinamine ditosylate monohydrate (0.002 wt). Once the crystallisation was established water (6 vol) was added while maintaining the reaction temperature above 55C. The mixture was cooled to 5-15C over ca 2 hours. The solid was collected by filtration, washed with tetrahydrofuran/water (3: 7 ratio, 2 x 2 vol) and dried in vacuo at 45C to give N- {3- Chloro-4- [ (3-fluorobenzyl) oxy] phenyl}-6- [5- ( { [2- (methane sulphonyl) ethyl] amino} methyl)-2-furyl]-4-quinazolinamine ditosylate monohydrate as a bright yellow crystalline solid.
With water; In tetrahydrofuran; at 5 - 64℃; for 2.5 - 4h;Heating / reflux; A suspension of the anhydrous ditosylate salt of N-{3-Chloro-4-[(3- fluorobenzyl)oxy]phenyl}-6-[5-([2-(methane sulphonyl) ethyl]amino}methyl)-2-furyl]-4- quinazolinamine (1 wt), in tetrahydrofuran (THF, 14 vol) and water (6 vol) was heated to ca 55-60C for 30 minutes to give a solution which was clarified by filtration and the lines washed into the crystallisation vessel with THF/Water (7:3, 2 vol). The resultant solution was heated to reflux and tetrahydrofuran (9 vol, 95% w/w azeotrope with water) was distilled off at atmospheric pressure. The solution was seeded with N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-([2-(methane sulphonyl) ethyl]amino}methyl)-2-furyl]-4-quinazolinamine ditosylate monohydrate (0.002 wt). Once the crystallisation was established water (6 vol) was added while maintaining the reaction temperature above 55C. The mixture was cooled to 5-15C over ca 2 hours. The solid was collected by filtration, washed with tetrahydrofuran/water (3:7 ratio, 2 x 2 vol) and dried in vacuo at 450C to give N-{3- Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-([2-(methane sulphonyl) ethyl] amino}methyl)-2-furyl]-4-quinazolinamine ditosylate monohydrate as a bright yellow crystalline solid.; A slurry of lambda/-(3-chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-([2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine 4- methylbenzenesulfonate hydrate (1.00 rel. wt) in aqueous tetrahydrofuran (80:20 THF: Water, 17 vols.) is heated to 63-64C and held for at least 30 min until a solution forms. The solution is clarified while hot and a line wash applied (80:20 <n="48"/>THF: Water, 0.5 vol.). THF (15.5 vols) is added over ca. 1 hour whilst maintaining the temperature at 60-630C and the solution seeded with GW572016F (0.002 rel. wt). The batch is maintained at 60-630C for at least 30 minutes to allow crystallization to become established. The batch is cooled to ca. 5C over ca. 2 hours and the product isolated by filtration. It is washed twice with aqueous THF (90:10 THF: Water, 2 x 2 vols.) followed once with aqueous THF (19:1 THF: Water, 1 x 2 vols.). The batch is dried under vacuum up to 45C to give lambda/-(3-chloro-4-[(3- fluorophenyl)methyl]oxy}phenyl)-6-[5-([2-(methylsulfonyl)ethyl]amino}methyl)-2- furanyl]-4-quinazolinamine 4-methylbenzenesulfonate hydrate as a bright yellow crystalline solid.
  • 3
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
In tetrahydrofuran; water; at 60 - 64℃; for 1h;Product distribution / selectivity; A slurry of Lambda/-(3-chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5- ([2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine 4- methylbenzenesulfonate hydrate (1.00 rel. wt) in aqueous tetrahydrofuran (80:20 THF: Water, 17 vols.) is heated to 63-640C and held for at least 30 min until a solution forms. The solution is clarified while hot and a line wash applied (80:20 THF: Water, 0.5 vol.). THF (15.5 vols) is added over ca. 1 hour whilst maintaining the temperature at 60-630C and the solution seeded with GW572016F (0.002 rel. wt). The batch is maintained at 60-630C for at least 30 minutes to allow crystallization to become established. The batch is cooled to ca. 5C over ca. 2 hours and the product isolated by filtration. It is washed twice with aqueous THF (90:10 THF: Water, 2 x 2 vols.) followed once with aqueous THF (19:1 THF: Water, 1 x 2 vols.). The batch is dried under vacuum up to 45C to give Lambda/-(3-chloro-4-[(3- fluorophenyl)methyl]oxy}phenyl)-6-[5-([2-(methylsulfonyl)ethyl]amino}methyl)-2- furanyl]-4-quinazolinamine 4-methylbenzenesulfonate hydrate as a bright yellow crystalline solid
YieldReaction ConditionsOperation in experiment
92% In methanol; at 40℃; for 2.5h;Purification / work up; Example 9: N-[3-Chloro-4-[(3-fluorobenzyl)oxylphenyll-6-r5-rrr2- (methylsulfonyl)ethyl] amino] methyll-2-furyll-4-quinazolinamine ditosylate (lapatinib Ditosylate) purification[00092] 1.0 g of lapatinib Ditosylate (purity determined by HPLC: 98.0%) was triturated in 10 ml of methanol at 400C for 2.5 hours, filtered, washed with the same solvent and dried to afford 0.92 g (yield - 92%) of pure material (purity determined by HPLC: 98.5%).
83% Example 5b. Purification of <strong>[388082-78-8]lapatinib ditosylate</strong>.<strong>[388082-78-8]Lapatinib ditosylate</strong> (3 g, 3.25 mmol, 99.3% HPLC purity was dissolved in DMF (18 mL) at 80C and stirred for 1 hour. The mixture was hot-filtered. MeCN (18 mL) was added into the filtrate at 80C. The temperature was cooled to 70C and crystal precipitated. The mixture was kept at 70C for 1 h and then 60C for 1 h. The mixture was further cooled to 0C and stirred for 2 h. The crystals of <strong>[388082-78-8]lapatinib ditosylate</strong> were isolated by filtration and were dried at 40C under vacuum overnight. <strong>[388082-78-8]Lapatinib ditosylate</strong> (2.5 g, 2.70 mmol, 83% yield) with 99.9% HPLC purity was obtained. XRPD analysis (figure 9) indicated that this was Form 2 as disclosed in WO 2009/079541 Al.
In N,N-dimethyl-formamide; at 25℃; for 2h;Purification / work up; Example 2To 50 mg of crystalline anhydrous <strong>[388082-78-8]lapatinib ditosylate</strong> sample, a solvent was added and the resulting suspension was stirred and filtered. The various conditions are summarized in the following table: stirring Experiment stirring time temperature no. solvent amount (V) (h) ( C.) result 1 DMF 5 2 25 II 2 NMP 5 2 25 V
In water; isopropyl alcohol; at 75 - 80℃;Purification / work up; (or) <strong>[388082-78-8]Lapatinib ditosylate</strong> monohydrate l(c)Into a two liter four-necked round bottomed flask, 1000 mL of 70% isopropylalcohol in water, 25 g of <strong>[388082-78-8]Lapatinib ditosylate</strong> salt obtained from previous step- (vi) were charged. The mass temperature was raised to 75 to 80C and stirred for 20-30 minutes to dissolve the product completely. Then solution was clarified by carbon treatment and filtered. The filtrate was cooled to 30-350C under stirring. The product was filtered and dried at 70-75C under vacuum till water content was around 2% w/w to get 23.0 g of yellow coloured Lapatinib. ditosylate monohydrate. Purity : 99.9% by HPLC Water content: 2.0 % w/w (1.91% w/w by theory) Particle size range: D50: 5-15mum and D90: 30-60 mum
In tetrahydrofuran; water; at 55 - 60℃; for 0.5h;Heating / reflux;Purification / work up; A suspension of the ditosylate monohydrate salt of N-{3-Chloro-4-[(3- fluorobenzyl)oxy]phenyl}-6-[5-([2-(methane sulphonyl) ethyl]amino}methyl)-2-furyl]- 4-quinazolinamine - compound G (1 wt), in tetrahydrofuran (THF, 14 vol) and water (6 vol) was heated to ca 55-60C for 30 minutes to give a solution which was clarified by filtration and the lines washed into the crystallisation vessel with THF/Water (7:3 ratio, 2 vol). The resultant solution was heated to reflux and tetrahydrofuran (9 vol, 95% w/w azeotrope with water) was distilled off at atmospheric pressure.The solution was seeded with N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6- [5-([2-(methane sulphonyl) ethyl]amino}methyl)-2-furyl]-4-quinazolinamine ditosylate monohydrate (0.002 wt). Once the crystallisation was established water (6 vol) was added while maintaining the reaction temperature above 550C. The mixture was cooled to 5-15C over ca 2 hours. The solid was collected by filtration, washed with tetrahydrofuran/water (3:7 ratio, 2 vol) then tetrahydrofuran/water (19:1 ratio, 2 vol) and dried in vacuo at 450C to give N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5- ([2-(methane sulphonyl) ethyl] amino}methyl)-2-furyl]-4-quinazolinamine ditosylate monohydrate - compound G as a bright yellow crystalline solid.
In water; isopropyl alcohol; at 75 - 80℃; (viii) Preparation of N{3-chIoro-4-[(3-fluoroben-iyloxy]phenyl}-6-[5-([2-methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamineditosylate monohydrate (or) <strong>[388082-78-8]Lapatinib ditosylate</strong> monohydrate 1(c)Into a two liter four-necked round bottomed flask, 1000 mL of 70% isopropylalcohol in water, 25 g of <strong>[388082-78-8]Lapatinib ditosylate</strong> salt obtained from previous step- (vii) were charged. The mass temperature was raised to 75 to 80C and stirred for 20-30 minutes to dissolve the product completely. Then solution was clarified by carbon treatment and filtered. The filtrate was cooled to 30-35C under stirring. The product was filtered and dried at 70-75C under vacuum till water content was around 2% w/w to get 23.0 g of yellow coloured <strong>[388082-78-8]Lapatinib ditosylate</strong> monohydrate.Purity : 99.9% by HPLCWater content: 2.0 % w/w (1.91% w/w by theory)Particle size range: D50: 5-15 etaiota and D90: 30-60 mu?iota
In water; at 20℃; for 36h;Inert atmosphere;Purification / work up; Example 8 - Preparation of <strong>[388082-78-8]Lapatinib ditosylate</strong> monohydrate formula (I-bis) - exemplifying the invention. In a 4-neck glass flask provided with a mechanical stirrer, condenser and thermometer, 50.0 g of <strong>[388082-78-8]Lapatinib ditosylate</strong> and 500 mL of water were introduced under nitrogen. Stirring is carried out for 36 hours at ambient temperature. Filtration is carried out draining the product thoroughly and the product is washed using the mother liquors. The product is dried at ambient temperature under the flow of nitrogen in a flask provided with a stirrer. The product is thus dried for 24 hours at 55C up to K.F. around 1.92%. There are obtained 51 g of product for a quantitative molar yield. [Show Image] 1H NMR (400 MHz, DMSO-d6): 2.31 (s, 6 H, CH3 (TsOH)); 3.17 (s, 3 H, CH3SO2); 3.50-3.65 (m, 4 H, -SO2CH2CH2NH-); 4.52 (s, 2, NH-CH2-furan); 5.35 (s, 2 H, ArO-CH2-Ar); 6.93 (d, J = 3.4 Hz, 1 H, CH (furan)) ; 7.14 (d, J = 7.8 Hz, 4 H, CH(TsOH)); 7.24 (dt, J = 8.8, 2.1 Hz, 1 H, Ar); 7.32 (d, J = 3. 4 Hz, 1 H, CH (furan)) ; 7.53 (d, J = 8.0 Hz, 4 H, CH(TsOH)); 7.65 (dd, J = 8.9, 2.5 Hz, Ar); 7.90 (d, J = 2.6 Hz, 1H, H-5'); 7.97 (d, J = 8.8 Hz, 1 H, H-8'); 8.48 (dd, J = 8.8, 1.5 Hz, 1 H, H-7'); 8.99 (s, 1 H, H-2'); 9.10 (s, 1 H, Ar); 9.40 (br. s, 1 H, NH); 11.48 (s, 1 H, NH).
In water; at 20℃; for 36h;Inert atmosphere;Purification / work up; In a 4-neck glass flask provided with a mechanical stirrer, condenser and thermometer, 50.0 g of <strong>[388082-78-8]Lapatinib ditosylate</strong> and 500 mL of water were introduced under nitrogen. Stirring was carried out for 36 hours at ambient temperature. Filtration was carried out draining the product thoroughly and the product was washed using the mother liquors. The product was dried at ambient temperature under the flow of nitrogen in a flask provided with a stirrer.The product was thus dried for 24 hours at 55 C. up to K.F. around 1.92%. 51 g of product were obtained for a quantitative molar yield. 1H NMR (400 MHz, DMSO-d6): 2.31 (s, 6H, CH3(TsOH)); 3.17 (s, 3H, CH3SO2); 3.50-3.65 (m, 4H, -SO2CH2CH2NH-); 4.52 (s, 2, NH-CH2-furan); 5.35 (s, 2H, ArO-CH2-Ar); 6.93 (d, J=3.4 Hz, 1H, CH(furan)); 7.14 (d, J=7.8 Hz, 4H, CH(TsOH)); 7.24 (dt, J=8.8, 2.1 Hz, 1H, Ar); 7.32 (d, J=3.4 Hz, 1H, CH(furan)); 7.53 (d, J=8.0 Hz, 4H, CH(TsOH)); 7.65 (dd, J=8.9, 2.5 Hz, Ar); 7.90 (d, J=2.6 Hz, 1H, H-5'); 7.97 (d, J=8.8 Hz, 1H, H-8'); 8.48 (dd, J=8.8, 1.5 Hz, 1H, H-7'); 8.99 (s, 1H, H-2'); 9.10 (s, 1H, Ar); 9.40 (br. s, 1H, NH); 11.48 (s, 1H, NH).

  • 5
  • N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-([2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine bis(4-methylbenzenesulphonate) monohydrate [ No CAS ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
73% In methanol; N,N-dimethyl-formamide; at 20 - 67℃;Heating / reflux;Product distribution / selectivity; Preparation of Anhydrate Form 2 by seeded recrystallisation of lapatinib ditosylate monohydrate: Lapatinib ditosylate monohydrate (10.0 g) was heated to reflux in a mixture of methanol (330 ml) and dimethylformamide (70 ml) and the solution was stirred at reflux temperature (67C) for 5 minutes. The heat source was switched off but not removed so that the solution cooled slowly. When the temperature had dropped to 62C, 2%w/w anhydrate Form 2 seed (0.2 g) was added to the solution. Crystals began to precipitate gradually and below 55C the heat source was removed completely so that the suspension was allowed to cool naturally and left to stand at ambient temperature overnight. The product was easily filtered and dried in the vacuum oven at 40-450C for 6 hours. Yield 7.34 g (73%). An X-ray powder diffraction pattern and an infrared spectrum were obtained and are depicted in Figure 1 (a) and Figure 1 (b) respectively. (d) Single crystal structure dataSingle crystal of crystalline anhydrate form 2 was obtained by recrystallisation of the monohydrate form prepared by methods similar to those disclosed in International Patent Application No. PCT/US01 /20706, filed June 28, 2001 , and published as WO 02/02552 on January 10, 2002, from DMF containing a small amount of acetonitrile as an antisolvent.Crystal structure data for anhydrate Form 2 was collected on a Bruker Smart CCD 6000 X-ray diffractometerEmpirical formula C29H28CIFN4O4S 2C7H7O3S Formula weight 925.44Temperature 223(2) KWavelength 0.71073 ACrystal system TriclinicSpace group P -1 Unit cell dimensions a = 9.5074(4) A alpha= 101.897(2). b = 15.4852(6) A beta= 99.888(2).C = 15.5537(7) A Y = 100.911(2).Volume 2146.61 (16) A3Z 2 Density (calculated) 1.432 Mg/m3
In 2,2,2-trifluoroethanol; at 20℃; Lapatinib ditosylate monohydrate (1.0 g) was dissolved in 2,2,2-trifluoroethanol (50 ml) at ambient temperature. The solution was concentrated using a rotary evaporator to give a solid residue which was dried in the vacuum oven at 400C for 3 hours. An X-ray powder diffraction was run which indicated the sample was mostly non-crystalline.
  • 6
  • [ 388082-78-8 ]
  • [ 231277-92-2 ]
YieldReaction ConditionsOperation in experiment
96.2% Example 17 Liberation of lapatinib base from <strong>[388082-78-8]lapatinib ditosylate</strong> monohydrate 5.400 g (5.72 mmol) <strong>[388082-78-8]lapatinib ditosylate</strong> monohydrate salt was vigorously stirred in 100 cm3 ethyl acetate for 60 minutes (Heidolph MR 3001, 500 rpm) at room temperature. 50 cm3 10 w/w% aqueous sodium carbonate solution is added thereto then the mixture is stirred for a further hour. After separation of the phases 35 cm3 water is added to the ethyl acetate phase then at 50 C it is stirred for a further 15 minutes. The phases are separated, the organic phase is dried on magnesium sulphate. After filtering out the drying material the obtained clear solution is evaporated. The residue is stirred with tert-buthyl methyl ether for 20 minutes then the solid material is filtered and dried on air. Yield: 3.200 g (96.2 %) Melting point: 142.3-145.5 C
91% With sodium carbonate; In water; acetonitrile; at 5 - 40℃; for 3.58333h; Preparation of Lapatinib Base Form X In a 500 ml round-bottomed flask equipped with a mechanical stirrer and a condenser were added 10.8 g of wet <strong>[388082-78-8]Lapatinib ditosylate</strong> (i.e., <strong>[388082-78-8]Lapatinib ditosylate</strong> which was not dried in a vacuum oven) and 60 ml of acetonitrile. The resulted suspension was stirred at 40 C. for 1 hour. A solution of 1.24 g of sodium carbonate in 70 ml of water was added drop-wise during 5 minutes. The resulted yellow suspension was stirred at 40 C. for 1 hour. Then, it was stirred at 25 C. for 2 hours, at 5 C. for 0.5 hours. The product was filtered in vacuum and dried for 48 hours in a vacuum oven at 35 C. Yield: 6.2 g (91%)
56% With sodium carbonate; In water; ethyl acetate; at 22 - 70℃; for 3.25h; Lapatinib free base was prepared as follows. A suspension of <strong>[388082-78-8]lapatinib ditosylate</strong> and ethyl acetate was stirred at 22+3C. An aqueous sodium carbonate solution (10%w/v) was added and the mixture stirred for at least 60 min. The layers were separated and the upper organic layer stirred with water (x 2) at 52+3C. The layers were separated and the upper organic layer clarified. The contents were cooled to 22+/-3C and the bottom aqueous layer is removed. The contents were then concentrated by atmospheric distillation to 9vol. The solution was cooled to 68-70 and seeded with lapatinib free base. The mixture was stirred at 68-70 for at least 15 min to allow crystallisation to establish, then concentrated by atmospheric distillation to 4vol. The mixture was cooled to 22+5 over at least 1h and aged for at least 1h. The product was isolated by filtration and washed with ethyl acetate. The product was dried in vacuo at 45+/-3C to give lapatinib free base as a cream solid. Expected yield: 90% theory; 56% w/w.
A suspension of <strong>[388082-78-8]lapatinib ditosylate</strong> and ethyl acetate was stirred at 22+/-3C. An aqueous sodium carbonate solution (10%w/v) was added and the mixture stirred for at least 60 min. The layers were separated and the upper organic layer was stirred with water (x 2) at 52+/-3C. The layers were separated and the upper organic layer was clarified. The contents were cooled to 22+/-3C and the bottom aqueous layer was removed. The contents were then concentrated by atmospheric distillation to 9 vol. The solution was cooled to 68-70 and seeded with lapatinib. The mixture was stirred at 68- 70 for at least 15 min to allow crystallisation to establish, then concentrated by atmospheric distillation to 4vol. The mixture was cooled to 22+/-5 over at least 1 hour and aged for at least 1 hour. The product was isolated by filtration and washed with ethyl acetate. The product was dried in vacuo at 45+/-3C to give GW572016X as a cream solid. Yield: 56% w/w. An X-ray powder diffraction pattern and an infrared spectrum were obtained and are depicted in Figure 1 (a) and Figure 1 (b) respectively.
With sodium hydroxide; In water; A solution of <strong>[388082-78-8]lapatinib ditosylate</strong> was converted to its free base form, lapatinib, by washing a solution with aqueous NaOH followed by concentration. Lapatinib: XH NMR (300 MHz, d6-DMSO): delta 2.98 (t, / = 6.75 Hz, 1H), 3.04 (s, 1H), 3.29 (t, J = 6.6 Hz, 1H), 3.83 (s, 1H), 5.28 (s, 1H), 6.50 (d, / = 3.0 Hz, 1H), 7.08 (d, / = 3.3 Hz, 1H), 7.20 (m, 1H), 7.33 (m, 4H), 7.48 (m, 1H), 7.76 (m, 1H), 7.80 (d, 7 = 9 Hz, 1H), 8.04 (d, 7 = 2.75 Hz, 1H), 8.17 (dd, / = 8.7 Hz, / = 1.8 Hz, 1H), 8.56 (s, 1H), 8.75 (d, J = 1.8 Hz, 1H).

  • 7
  • [ 388082-78-8 ]
  • [ 185331-04-8 ]
  • [ 1204307-72-1 ]
YieldReaction ConditionsOperation in experiment
63% 110] Step 1. (Bis(benzyloxy')phosphoryloxy')methyl (5-(4-(3-chloro-4-(3- fluorobenzyloxy)phenylamino)quinazolin-6-yl)mran-2-yl)methyl(2- (methylsulfonyliethvDcarbamate (22). To a suspension of 20 (988 mg, 1.07 mmol, prepared as described in US Patent No. 6,727,256) in dichloromethane (15.0 mL) was added triethylamine (602 muL, 4.32 mmol). The reaction mixture was stirred at room temperature until a yellow homogeneous solution was obtained (approximately 10 minutes). (Bis(benzyloxy)phosphoryloxy)methyl carbonochloridate (21) (788 mg, 1.62 mmol, prepared according to the procedure of Scola, PM et al., EP 0747385A1) was added and the mixture was stirred for 18 hours. The crude mixture was concentrated in vacuo and the residue purified by column chromatography (silica gel, 0 - 5% methanol / dichloromethane) to afford pure 22 as a yellow solid (617 mg, 63%). MS (M+H): 915.2. 1111]
  • 8
  • [ 104458-24-4 ]
  • [ 104-15-4 ]
  • [ 231278-84-5 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
94.9% In a 1 L reaction flask, 650 ml of tetrahydrofuran was added in that order.Compound IV 40 g (85 mmol), compound V17.5 g (110 mmol),50 ml of triethylamine and 1.63 g (5 mmol) of tetrabutylammonium bromide were reacted at 30 C for 3 hours. At the end of the reaction, 32.3 g (152 mmol) of sodium triacetoxyborohydride was added in portions.The feeding temperature does not exceed 20 C, the reaction is 4 hours, the reaction is finished, 200 ml of 1 M sodium hydroxide is added dropwise, the pH is adjusted to 8, the dropping temperature does not exceed 30 C, and the dropwise addition is finished.The mixture was allowed to stand for separation, and 56.2 g (296 mmol) of p-toluenesulfonic acid was added to the organic layer.The temperature was raised to 50 C, the reaction was carried out for 1 hour, the temperature was lowered to room temperature, and dried by filtration to obtain 75.8 g of a yellow solid.That is, compound VI, the yield is 94.9%, and the HPLC purity is 99.72%.The largest single impurity is 0.18%.
82.8% A solution of 5- [4 - [[3-chloro-4 - [(3-fluorophenyl) methoxy] phenyl] amino] -6-quinazoline] -2-furancarboxaldehyde (4 . & Lt; / RTI & gt;2- (amino) ethylmethylsulfone hydrochloride (2. 56 g, 16 mmol),Diisopropylethylamine (5. 17 g, 40 mmol),Acetic acid (2.4 g, 40 mmol) and 50 ml of tetrahydrofuran,Stirring reaction at room temperature 3h,Sodium triacetoxyborohydride (8. 48 g, 40 mmol) was added in portions,Room temperature reaction 12h.30 ml of 20% sodium hydroxide solution was added to the solution,The organic phase was extracted with ethyl acetate.The organic phases were combined,concentrate,The residue was dissolved in 50 ml of tetrahydrofuran,An aqueous solution of p-toluenesulfonic acid (7. 6 g, 40 mmol / 15 ml) was added,Stir at room temperature for 12h,filter,The cake was dried to give a pale yellow solid of 7. 58 g, m.p. 244-246 C, yield 82.8%, and HPLC purity 99.6%.
72% Example 23: preparation of lapatinib ditosylate.[000121] 100.0 gr (0.211 mol) of lapatinib aldehyde and 54.6 gr (0.342 mol) of methylsulfonylethylamine HCl were mixed with 500 ml THF and 100 ml DMF. 48 ml acetic acid and 147 ml diisopropylethylamine were added. The reaction mixture was heated to 35C and stirred at this temperature for 1 hour and cooled to 20-250C. 111.8 gr (0.528 mol) of sodium triacetoxyborohydride were added and stirred for additional 2 hours to complete the reaction.[000122] 1500 ml ethyl acetate and 300 ml water were added to the reaction mixture.Then 110 ml of 47% sodium hydroxide solution was added. The mixture allowed for the phase separation. The organic phase was washed twice with 500 ml of 25% aqueous ammonium chloride solution. The resulting organic phase was washed twice with 300 ml of water. The resulting organic solution was concentrated to dryness. 350 ml of DMF is added to the evaporation residue to form lapatinib solution in DMF.[000123] The resulting organic solution was heated to about 400C and filtered to remove foreign particles. 263 ml DMF were added to the filtrate and heated again to about 400C. 80.3 g (0.442 mol) of p-toluenesulfonic acid were added to the lapatinib solution in DMF. The solution was seeded with pure lapatinib ditosylate and cooled slowly from 400C to about 00C for 6 hours. The formed slurry was stirred at about 00C for 9 hours, cooled additionally to about (-10)C to complete precipitation and stirred at this temperature during 2 hours. The crude product was filtered and washed with 60 ml of cold DMF to get 248.2 gr of wet lapatinib ditosylate crude.[000124] 244.8 gr of the wet lapatinib ditosylate crude were slurried in 490 ml of DMF at about 400C during 2 hours, cooled to about (-10)C during 2 hours and stirred at this temperature during additional 17 hours. The precipitated product was filtered, washed with 60 ml DMF and dried at 700C under reduced pressure during overnight to give 133.7 gr (72% yield) of the lapatinib ditosylate purity: 99.73%.
5-{4-[(3-Chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)amino]-6- quinazolinyl}-2-furancarbaldehyde 4-methylbenzenesulfonate (1 wt) and 2-(methylsulfonyl)ethylamine hydrochloride (0.4 wt, 1.60 equiv.) are suspended in THF (10 vols). Sequentially, acetic acid (0.354 vol., 4.00 equiv.) and di- isopropylethylamine (DIPEA, 1.08 vols, 4.00 equiv.) are added. The resulting solution is stirred at 30-35C for ca. 1 hour then cooled to ca. 22C. Sodium tri- acetoxyborohydride (0.66 wt, 2.00 equiv.) is then added. The resulting mixture is stirred at ca. 22C for 2-4 hours then sampled for HPLC analysis. The reaction is quenched by addition of aqueous sodium hydroxide (25% w/w, 3 vols.) followed by water (2 vols.). The aqueous phase is then separated, extracted with THF (2 vols) and the combined THF extracts are then washed twice with 25%w/v aqueous ammonium chloride solution (2 x 5 vols). A solution of p-toluenesulfonic acid monohydrate (p-TSA, 0.74 wt, 2.5 equiv.) in water (1 vol) is prepared, warmed to ca. 6O0C, and N-(3-chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-([2- (methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine 4- methylbenzenesulfonate hydrate seeds are added. The THF solution of the free base is added to the p-TSA solution over at least 1 hr, maintaining the batch EPO <DP n="49"/>temperature at 60+30C. The resulting suspension is stirred at ca. 600C for 1-2 hours, cooled to 20-250C over an hour and aged at this temperature for ca. 1hr. The solid is collected by filtration, washed with 95:5 THF: Water (3 x 2 vols) and dried in vacuum at ca. 35C to give Lambda/-(3-chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5- ([2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine 4- methylbenzenesulfonate hydrate as a bright yellow crystalline solid.

  • 9
  • 5-(4-[3-chloro-4-(3-fluorobenzyloxy)-anilino]-6-quinazolinyl)-furan-2-carbaldehyde 4-methylbenzenesulfonate [ No CAS ]
  • [ 104458-24-4 ]
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
Example 11 : Preparation of lapatinib ditosylate[00095] 1.0 gr "Intermediate-D" (compound of Formula D), 0.4 gr methylsulfonylethylamine hydrochloride, 10 ml methanol, 0.35 ml acetic acid and 1.1 ml N,N-diisopropylethylamine were mixed at 5-100C. The resulting reaction mixture was stirred at 5-100C for an hour. Afterwards, 0.2 gr of sodium cyanoborohydride were added in two equal portions with 3 hours interval (2 x 0.1 gr). The resulting mixture was stirred at 5-100C for additional 16 hours. The reaction mixture is quenched with 3 ml of 25% NaOH aq. and 2 ml of water. The resulting mixture is stirred for 0.5 hours. The aqueous phase is separated and washed with 2.5 ml of THF. The combined THF extracts are washed with 25% aq. ammonium chloride (2 x 5 ml).[00096] The resulting THF solution is mixed with 0.67 gr of p-toluenesulfonic acid dissolved in 1 ml water at about 600C. Then it is cooled to 25-300C. 1 ml of water is added to the prepared solution. The mixture is cooled to 0-50C to obtain yellow precipitation. The precipitated solid is filtered and dried to afford lapatinib ditosylate. Purity by HPLC: 91.76%
Compound F (1 wt) and 2-(methylsulfonyl)ethylamine hydrochloride (0.4 wt, 162 equiv.) were suspended in THF (10 vols). Sequentially, acetic acid (0.354 vol., 4 equiv.) and di-isopropylethylamine (DIPEA, 1.08 vol., 4.07 equiv.) were added. The resulting solution was stirred at 30-35C for ca 1 hour then cooled to ca 22C. Sodium tri-acetoxyborohydride (0.66 wt, 2.01 equiv.) was then added as a continual charge over approximately 15 minutes (some effervescence is seen at this point). The resulting mixture was stirred at ca 22C for ca 2 hours then sampled for HPLC analysis. The reaction was quenched by addition of aqueous sodium hydroxide (25% w/w, 3 vols.) followed by water (2 vols.) and stirred for ca 30 minutes (some effervescence was seen at the start of the caustic addition).The aqueous phase was then separated, extracted with THF (2 vols) and the combined THF extracts were then washed twice with 25% w/v aqueous ammonium chloride solution (2 x 5 vols)2. A solution of p-toluenesulfonic acid monohydrate (p- TSA, 0.74 wt, 2.5 equiv.) in water (1 vol)1 was prepared, warmed to ca 6O0C, and GW572016F (Compound G) (0.002 wt) seeds were added.The THF solution of the free base of GW572016 was added to the p-TSA solution over at least 30 minutes, while maintaining the batch temperature at 60+/-3C. The resulting suspension was stirred at ca 600C for 1-2 hours, cooled to 20-250C over an hour and aged at this temperature for ca 1hr. The solid was collected by filtration, washed with 95:5 THF:Water (3 x 2 vols) and dried in vacuo at ca 35C to give GW572016F - compound G as a bright yellow crystalline solid. Expected yield 80% theory, 117% w/w.1 Minimum reaction volume ca 1 vol.2 Maximum reaction volume ca 17 vol.No. Corrected for assay.
  • 10
  • [ 1885-29-6 ]
  • [ 388082-78-8 ]
  • 13
  • [ 132131-24-9 ]
  • [ 388082-78-8 ]
  • 14
  • [ 903597-10-4 ]
  • [ 388082-78-8 ]
  • 17
  • [ 1227853-05-5 ]
  • [ 388082-78-8 ]
  • 18
  • [ 13529-27-6 ]
  • [ 388082-78-8 ]
  • 19
  • N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-([2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazoline-4-amine hydrochloride [ No CAS ]
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
90.1% Example 7 - Preparation of Lapatinib of formula (I) as a ditosylate salt - exemplifying the invention. In a 4-neck glass flask provided with a mechanical stirrer, condenser and thermometer, 9.70 g of Lapatinib chlorohydrate (15.7 mmoles), 120 ml of ethyl acetate and 25 mL of purified water were introduced under nitrogen. About 4.6 g of NaOH 30% solution (p/p) are dripped up to a pH of about 10. The phases are separated and the organic phase is washed with 2x30 mL of purified water. The organic phase is concentrated under vacuum to dryness. The residue is recovered using 28 mL of dimethylformamide. Heating is carried out at 40C for 15 minutes and filtration is carried out on a dicalite panel. The panel is washed with 21 ml of dimethylformamide pre-heated at 50C. The organic phases are combined, they are brought to 40C and they are added portionwise with 6.74 g of paratoluenesulfonic acid monohydrate (2.25 mol. equiv.). Stirring is carried out at 40C for 1 hour and then cooling is carried out within 3-4 hours at 0C. 0.08 g of Lapatinib ditosylate are added to initiate the precipitation and stirring is carried out for 4 hours at 0C, then cooling is carried out at -10C and stirring is carried out for 2 hours. The suspension is filtered and the solid is washed with 4.8 mL of dimethylformamide pre-cooled to -10C. The product is dried under vacuum at 70C for at least 10 hours. 13.1 g of product are obtained with a molar yield equivalent to 90.1%.
  • 25
  • [ 49773-20-8 ]
  • [ 104-15-4 ]
  • [ 231278-84-5 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
93% Example 7:Preparation of A/-(3-chloro-4-[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-([2- (methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine bis 4- methylbenzenesulfonate.The suspension of 5-[4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde (5 g, 10.6 mmoL) in dichloromethane (50ml_) was charged with a solution of 2-aminoethylmethylsulfone (3.2 g, 1 1.7mmoL) in methanol (25ml_) slowly under constant stirring at room temperature. The reaction mixture was stirred for 2-4 hours until reaction completion. The reaction mixture was charged with 5% Pd-C (750mg) and stirred under hydrogen atmosphere using balloon pressure for 12-16 hours until reaction completion. The obtained mixture was filtered through Celite pad and rinsed with methanol (5 mL) and dichloromethane (15 mL) mixture. The filtrate was distilled to low volume and the solution was charged with dichloromethane (25 mL) followed by addition of the solution of p-toluenesulfonic acid monohydrate (4.4 g, 23.3 mmoL) in methanol (10 mL). The yellow solid which precipitated out was filtered after 2- 8 hours and washed with 1 :1 mixture of methanol and dichloromethane (20 mL). The solid obtained was dried under vacuum at 40-45C to provide Lapatinib (1 1.4 g, Yield = 93%, HPLC purity >99%).
YieldReaction ConditionsOperation in experiment
In N,N-dimethyl-formamide; at 40℃; for 1h; General procedure: The residue obtained from the concentration of the organic phase in Example 5 constituted by the compound of formula (I) (as a free base) was recovered using 52.5 mL of dimethylformamide. Heating was carried out at 40 C. for 15 minutes and filtration was carried out on a dicalite panel. The panel was washed using 39.5 ml of dimethylformamide pre-heated at 50 C. The organic phases were combined. They were brought to 40 C. and 12.64 g of monohydrate Paratoluenesolfonic acid (2.1 mol. equiv.) were added to subsequent portions. Stirring was carried out at 40 C. for 1 hour and then cooling was carried out in 3-4 hours at 0 C. Stirring was carried out for 1 hour a 0 C., then cooling was carried out at -10 C. and then stirring was carried out for 1 hour. The suspension was filtered and the solid was washed using 9 mL of Dimethylformamide pre-cooled at -10 C. The solid was recovered using 75 mL of DMF and pulping was carried out at 40 C. for 2 hours. Cooling was carried out slowly at -10 C. and stirring was carried out at this temperature for 1-2 hours, the solid was filtered and washed using 9 ml of DMF pre-cooled at -10 C. The solid was dried in an oven under vacuum at 70 C. for at least 10 hours. 21.4 g of product equivalent to a 73.0% molar yield were obtained. 1H-NMR spectrum according to FIG. 2.
  • 27
  • [ 1383531-68-7 ]
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
90.1% In a 4-neck glass flask provided with a mechanical stirrer, condenser and thermometer, 9.70 g of Lapatinib chloro-hydrate (15.7 mmoles), 120 ml of ethyl acetate and 25 mL of purified water were introduced under nitrogen.About 4.6 g of NaOH 30% solution (p/p) were dripped up to a pH of about 10. The phases were separated and the organic phase was washed with 2×30 mL of purified water. The organic phase was concentrated under vacuum to dryness.The residue was recovered using 28 mL of dimethylformamide. Heating was carried out at 40 C. for 15 minutes and filtration was carried out on a dicalite panel. The panel was washed with 21 ml of dimethylformamide pre-heated at 50 C. The organic phases were combined and brought to 40 C. They were added portionwise with 6.74 g of paratoluenesulfonic acid monohydrate (2.25 mol. equiv.). Stirring was carried out at 40 C. for 1 hour and then cooling was carried out within 3-4 hours at 0 C. 0.08 g of Lapatinib ditosylate were added to initiate the precipitation and stirring was carried out for 4 hours at 0 C., then cooling was carried out at -10 C. and stirring was carried out for 2 hours. The suspension was filtered and the solid was washed with 4.8 mL of dimethylformamide pre-cooled to -10 C. The product was dried under vacuum at 70 C. for at least 10 hours. 13.1 g of product were obtained with a molar yield equivalent to 90.1%.
  • 28
  • C21H23N3O5S [ No CAS ]
  • [ 388082-78-8 ]
  • 29
  • [ 1227853-06-6 ]
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
46.9% To a stirred mixture of Sodiumtriacetoxyborohydride (0.21 g) in Tetrahydrofuran (THF)(2.4 ml) was added N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2- (methylsulfonyl)ethylimino)- methyl)furan-2-yl)quinazolin-4-amine (0.2 g) in THF. The reaction mixture was stirred for 1 hour at 20-25 C. Reaction was monitored by TLC and on completion of reaction, aqueous NaQH (0.16 g NaOH to 0.8 g demineralized water) was added. The organic layer was separated and added p- Toluenesulfonic acid (0.42) in THF (0.6 ml) and stirred for 3 hours. The solid was filtered and dried under vacuum at 60-65C till constant weight. Weight: 0.15 g Yield: 46.9 % Purity by HPLC: 96.16% MS (ES+) m/z: 581 [M+H]+ & 583 [M+H+2]+ 1H NMR (400 MHz; DMSO-d6): 2.28 (s, 6H), 3.14 (s, 3H), 3.44 (t, J=8.0 Hz, 2H), 3.55 (t, J=8.0 Hz, 2H), 4.46 (s, 2H), 5.31 (s, 2H), 6.89 (br s, 1H), 7.10 (d, J=7.2 Hz, 4H), 7.20 (m, 1H), 7.23 (br s, 1H), 7.31- 7.36 (m, 3H), 7.47 (d, J=7.2 Hz, 4H), 7.63 (d, J=8.8 Hz, 1H), 7.89 (br s, 1H), 7.92 (d, J=8.8 Hz, 1H), 8.39 (d, J=8.8 Hz, 1H), 8.89 (s, 1H), 8.98 (s, 1H), 9.28 (s, 1H, NH), 11.18 (s, 1H, NH).
  • 31
  • [ 3964-52-1 ]
  • [ 388082-78-8 ]
  • 32
  • [ 908332-08-1 ]
  • [ 388082-78-8 ]
  • 33
  • [ 1440511-81-8 ]
  • [ 388082-78-8 ]
  • 34
  • [ 1440511-82-9 ]
  • [ 388082-78-8 ]
  • 35
  • [ 388082-78-8 ]
  • lapatinib dimalonate [ No CAS ]
  • 36
  • [ 388082-78-8 ]
  • lapatinib nitric acid salt [ No CAS ]
  • 37
  • [ 388082-78-8 ]
  • [ 1092929-12-8 ]
  • 38
  • [ 388082-78-8 ]
  • [ 1092929-27-5 ]
  • 39
  • [ 388082-78-8 ]
  • lapatinib naphthalene-1,5-disulfonic acid salt [ No CAS ]
  • 40
  • [ 388082-78-8 ]
  • lapatinib naphthalene-2-sulfonic acid salt [ No CAS ]
  • 41
  • [ 388082-78-8 ]
  • [ 1383531-68-7 ]
  • 42
  • [ 388082-78-8 ]
  • lapatinib dihydrochloride [ No CAS ]
  • 43
  • [ 388082-78-8 ]
  • lapatinib (1S)(+)-camphorsulfonic acid salt [ No CAS ]
  • 44
  • [ 388082-78-8 ]
  • lapatinib 2,5-dihydroxybenzoic acid salt [ No CAS ]
  • 45
  • [ 388082-78-8 ]
  • lapatinib malonic acid salt [ No CAS ]
  • 46
  • 5-(4-hydroxyquinazolin-6-yl)furan-2-carbaldehyde [ No CAS ]
  • [ 388082-78-8 ]
  • 47
  • (E/Z)-6-(5-((2-(methylsulfonyl)ethylimino)methyl)furan-2-yl)quinazolin-4-ol [ No CAS ]
  • [ 388082-78-8 ]
  • 48
  • [ 1618648-57-9 ]
  • [ 388082-78-8 ]
  • 49
  • [ 1618648-58-0 ]
  • [ 388082-78-8 ]
  • 50
  • [ 1618648-59-1 ]
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
2.5 g Into a 500 ml, four-necked, RB flask was charged 180 ml of methanol and 9.0 g of N- ((5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2- yl)methyl)-2,2,2-trifluoro-N-(2-(methylsulfonyl)ethyl)acetamide under stirring. Aqueous sodium hydroxide (2.52 g of sodium hydroxide dissolved in 22.5 ml of water) was added to the reaction mass at 25-30 C. The reaction mass was stirred for 2 h at 25-30 C. Solvent was evaporated under reduced pressure. Water (75 ml) was added to the residue and the product extracted into ethyl acetate. The organic layer was treated with carbon and distilled of solvent partially under reduced pressure. Residual mass was cooled to 25-30 C, stirred for 30 minutes, and filtered. The wet solid was dried in oven at 60 C to get 4.2 g of title compound. HPLC purity is 98.85%Preparation of N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2- (methyIsuIfonyl)ethyI-amino)methyI)furan-2-yl)quinazolin-4-amine ditosylate salt Into a 100 ml, four-necked, RB flask was charged methanol (60 ml) and 2.0 g of lapatinib base. The reaction mass was heated to reflex temperature and maintained for 30 minutes. The reaction mass was cooled to 45-50 C and added a solution of p- toluenesulfonic acid monohydrate (1.4 g dissolved in 10 ml of methanol). Reaction mass was maintained at reflux for 3 h, cooled to 25-30 C, filtered the mass, and dried at 60 C to get 2.5 g of lapatinib ditosylate. HPLC purity is 99.87%.
  • 51
  • [ 17420-30-3 ]
  • [ 388082-78-8 ]
  • 52
  • [ 6943-17-5 ]
  • [ 388082-78-8 ]
  • 53
  • [ 17329-31-6 ]
  • [ 388082-78-8 ]
  • 54
  • [ 1618648-59-1 ]
  • [ 388082-78-8 ]
  • 55
  • [ 1618648-60-4 ]
  • [ 388082-78-8 ]
  • 56
  • 5-(4-[3-chloro-4-(3-fluorobenzyloxy)-anilino]-6-quinazolinyl)-furan-2-carbaldehyde 4-methylbenzenesulfonate [ No CAS ]
  • [ 388082-78-8 ]
  • 57
  • [ 49773-20-8 ]
  • 5-(4-[3-chloro-4-(3-fluorobenzyloxy)-anilino]-6-quinazolinyl)-furan-2-carbaldehyde tosylate [ No CAS ]
  • [ 104-15-4 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
88% To a 20 L reactor was added 13.3 vol of THF followed by 0.62 wt (2.93 mol) of NaBH(OAc)3. The 20 L reactor was set to maintain contents at 20 C. A second 20 L reactor was charged with 1000 grams, (1.55 mol) of 5-(4-[3-chloro-4-(3-fluorobenzyloxy)-anilino]-6-quinazolinyl)-furan-2-carbaldehyde tosylate prepared by the procedure of Example 1 and 6.7 vol of THF. To the THF solution of 5-(4-[3-chloro-4-(3-fluorobenzyloxy)-anilino]-6-quinazolinyl)-furan-2-carbaldehyde tosylate was added 0.325 vol (1.86 mol) diisopropylethylamine followed by 0.32 wt of 2-(methylsulfone)ethylamine, (321 g, 2.6 mol) and 0.15 vol of IPA. After 1 hour, the preformed imine/THF solution was transferred by vacuum to the stirred suspension of NaBH(OAc)3 in the first 20 L reactor over 10 minutes. After 90 minutes, 4 vol of 5N NaOH was added over 40 minutes via a pump. This solution was allowed to stir for 15 minutes after which the stirrer was switched off and the layers were allowed to separate. The aqueous layer was drained from the bottom of the reactor and the organic layer transferred to the empty 20 L reactor through a teflon-lined stainless steel jacketed transfer hose outfitted with an in-line 0.45 mum filter. To this solution was added a 2 vol THF solution of 4 wt (1180 g, 6.2 mole) of p-toluenesulfonic acid monohydrate over 5 minutes. A yellowish precipitate was observed to come out of solution and this was allowed to stir at room temperature for 12 hours. The reaction was drained from the bottom of the reactor and filtered through a ceramic filter lined with paper. The yellow filter cake was washed with 1 vol of a 95:5 THF/water solution and allowed to air dry overnight. After suctioning dry for 12 hours, the yellow filter cake was transferred to two glass trays and placed in the drying oven (42 C.) under house vacuum (18 in Hg) with a nitrogen bleed. The two glass trays were removed from the oven and allowed to cool to room temperature and sampled accordingly. The isolated yield of N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-([2-(methane-sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine ditosylate (anhydrate) was 1264 grams (1.3 wt, 88%; 1443 g Th) and was a yellow solid. Approximately 50 mg of the product was transferred to a Karl Fisher Volumetric Moisture Apparatus (model DL35, Mettler, Hightstown, N.J.), which was operated according to the manufacturer's instructions. The anhydrate water content was determined to be 0.31%.
  • 58
  • [ 231277-92-2 ]
  • [ 388082-78-8 ]
YieldReaction ConditionsOperation in experiment
33% With toluene-4-sulfonic acid; In tetrahydrofuran; water; at 50℃; for 1h; A mixture of 50 mg of the starting material (5- (4- (3-chloro-4- (3-fluorobenzyloxy) phenylamino) -quinazolin-6-yl) furan-2-carbaldehyde synthesized in Example 5 Acid) was added to DCM (dichloromethane) (1 ml) and DIEA (N, N-diisopropylethylamine) (25 mg, 2 eq) was added,Stir to dissolve,And 2- (methylsulfonyl) ethylamine (24 mg, 2 eq) was added,The mixture was stirred at room temperature (18 C) until the starting reaction was completed,Evaporated to dryness under reduced pressure DCM (dichloromethane),And dissolved in THF (tetrahydrofuran) (1 ml)NaHB (OAc) 3 (124 mg, 6 eq) was added,Stirring at room temperature until the reaction of the raw material is completed,An aqueous Na2CO3 solution (1 ml, 5%) was added and extracted with EA (ethyl acetate) (1 ml * 2)Combined organic layer,Rinse with saturated brine (1 ml * 1)The organic layer is dried,Evaporated to dryness to give 50 mg of a brown oil.50 mg of a brown oil was dissolved in 1 ml of THF,Solution of p-toluenesulfonic acid monohydrate (33mg, 2eq) in THF (0.5ml),Raise the temperature to 50 C,After stirring for 1 hour,Cooled to room temperature (15 C)Filter,The filter cake was washed with THF (1 ml * 2) and dried to give 49 mg of a yellow solid,The yellow solid was added to 1 ml of THF / H2O (4/1)Heated to 60 C to dissolve and clarify,And the temperature was gradually lowered to room temperature (15 C) for 1 hour,Continue to lower the temperature to 0 C,After stirring for 1 hour,The filter cake was washed with THF (1 ml * 2)After drying in vacuo, 30 mg of a yellow solid was obtained.Yield: 33%, purity 99%
  • 59
  • [ 845271-71-8 ]
  • [ 388082-78-8 ]
  • 60
  • [ 388082-76-6 ]
  • [ 388082-78-8 ]
  • 61
  • [ 19815-16-8 ]
  • [ 388082-78-8 ]
  • 62
  • [ 616-79-5 ]
  • [ 388082-78-8 ]
  • 63
  • [ 851653-35-5 ]
  • [ 388082-78-8 ]
  • 64
  • [ 16064-08-7 ]
  • [ 388082-78-8 ]
  • 65
  • [ 202197-25-9 ]
  • [ 388082-78-8 ]
Same Skeleton Products
Historical Records